
New wave medicine: The clinical potential of non-hallucinogenic “designer psychedelics”
Sofia Luchanskaya discusses the clinical potential of psychedelics in treating mood and addiction disorders.
Sofia Luchanskaya discusses the clinical potential of psychedelics in treating mood and addiction disorders.
Catherine Baldwin discusses an unconventional journey to postgraduate education, and a series of tips for returning to education.
Ester Paolocci describes the social and biological consequences of private renting, particularly how the stress can alter our DNA.
Katerina Panti explores the paradigm shifts that have, and continue to, shape our understanding of schizophrenia.
Isabelle Goodall-Summers examines the neuroscience of grief highlighting physical and emotional responses to the loss of a loved one.
Leah Fogarty discusses the complexities and urgent need for research on Capgras delusion, a poorly understood psychiatric condition.
Leah Fogarty reports on the new link found between the microglia and anxiety, which might offer ways of treating the disorder.
Jasmin Patel discusses how psychedelics work, and how they might solve the current lack of effective treatments for mental health disorders.
Leah Fogarty reviews research into the intricate relationship between REM sleep and depression, and how it might lead to treatment.
Leah Fogarty reports on a new study that suggests brain waves known as gamma oscillations may be key to treating depression.